These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25250508)

  • 21. Structure-based virtual screening for novel ligands.
    Pitt WR; Calmiano MD; Kroeplien B; Taylor RD; Turner JP; King MA
    Methods Mol Biol; 2013; 1008():501-19. PubMed ID: 23729265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of a novel selective PPARγ ligand with partial agonist binding properties by integrated in silico/in vitro work flow.
    Kouskoumvekaki I; Petersen RK; Fratev F; Taboureau O; Nielsen TE; Oprea TI; Sonne SB; Flindt EN; Jónsdóttir SÓ; Kristiansen K
    J Chem Inf Model; 2013 Apr; 53(4):923-37. PubMed ID: 23432662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
    Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
    J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to benchmark methods for structure-based virtual screening of large compound libraries.
    Christofferson AJ; Huang N
    Methods Mol Biol; 2012; 819():187-95. PubMed ID: 22183538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.
    Greenidge PA; Kramer C; Mozziconacci JC; Sherman W
    J Chem Inf Model; 2014 Oct; 54(10):2697-717. PubMed ID: 25266271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical Screening of Nuclear Receptor Modulators.
    Ishigami-Yuasa M; Kagechika H
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand and decoy sets for docking to G protein-coupled receptors.
    Gatica EA; Cavasotto CN
    J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
    Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D
    J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient virtual screening using multiple protein conformations described as negative images of the ligand-binding site.
    Virtanen SI; Pentikäinen OT
    J Chem Inf Model; 2010 Jun; 50(6):1005-11. PubMed ID: 20504004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G-protein coupled receptors virtual screening using genetic algorithm focused chemical space.
    Sage C; Wang R; Jones G
    J Chem Inf Model; 2011 Aug; 51(8):1754-61. PubMed ID: 21761904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition.
    Wei NN; Hamza A
    J Chem Inf Model; 2014 Jan; 54(1):338-46. PubMed ID: 24328054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation.
    Johnson BA; Wilson EM; Li Y; Moller DE; Smith RG; Zhou G
    J Mol Biol; 2000 Apr; 298(2):187-94. PubMed ID: 10764590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of new Fyn kinase inhibitors using a FLAP-based approach.
    Poli G; Tuccinardi T; Rizzolio F; Caligiuri I; Botta L; Granchi C; Ortore G; Minutolo F; Schenone S; Martinelli A
    J Chem Inf Model; 2013 Oct; 53(10):2538-47. PubMed ID: 24001328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discovery.
    Kojetin DJ; Burris TP
    Mol Pharmacol; 2013 Jan; 83(1):1-8. PubMed ID: 22869589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synthetic ligands for nuclear receptors].
    Kato S
    Nihon Rinsho; 2010 Oct; 68(10):1830-4. PubMed ID: 20954325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extensive consensus docking evaluation for ligand pose prediction and virtual screening studies.
    Tuccinardi T; Poli G; Romboli V; Giordano A; Martinelli A
    J Chem Inf Model; 2014 Oct; 54(10):2980-6. PubMed ID: 25211541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
    Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
    J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel approach for efficient pharmacophore-based virtual screening: method and applications.
    Dror O; Schneidman-Duhovny D; Inbar Y; Nussinov R; Wolfson HJ
    J Chem Inf Model; 2009 Oct; 49(10):2333-43. PubMed ID: 19803502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An extensive and diverse set of molecular overlays for the validation of pharmacophore programs.
    Giangreco I; Cosgrove DA; Packer MJ
    J Chem Inf Model; 2013 Apr; 53(4):852-66. PubMed ID: 23565904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.